39748Tirzepatide sodium salt 1mg and 4 more items

Cayman Chemical Company Inc was awarded a contract by Virginia Commonwealth University on June 29, 2026, to supply pharmaceutical compounds to VCU Procurement in Virginia. The contract encompasses five distinct pharmaceutical line items with a cumulative value of $586. The deliverables include Semaglutide 1mg, Tirzepatide sodium salt 1mg, Liraglutide, Lixisenatide acetate 5mg, and Orforglipron 1mg, with quantities and unit prices varying across the line items. All materials are to be delivered to VCU Procurement.

The pharmaceutical compounds specified under this contract represent glucagon-like peptide-1 (GLP-1) receptor agonist medications and related compounds. Pricing for individual line items ranges from $31 to $86 per unit of measure (milligram), with the exception of Lixisenatide acetate, which is supplied in a quantity of 5 milligrams at $86 per unit price. The modest contract value and specific pharmaceutical nature of the deliverables indicate this procurement supports research, testing, or clinical operations conducted by Virginia Commonwealth University.